Dr. Janne Estill
Researcher, Mathematical modeller
+41 31 631 88 18
Janne Estill is a mathematician and epidemiological modeler in the division of infectious diseases and mathematical modelling. He studied Mathematics at the University of Helsinki (MSc in 2008). In 2010, he joined the Institute of Social and Preventive Medicine (ISPM), University of Bern, and, in 2013, completed his PhD in mathematical modelling of HIV in Olivia Keiser’s group. He continued at ISPM as a postdoctoral researcher until 2017. In 2017, he moved with Olivia’s group to the Institute of Global Health, Geneva. Dr. Estill’s research focuses on developing mathematical models for disease progression and transmission of HIV, hepatitis C, and other diseases. He applies such models to evaluate the impact and cost-effectiveness of health policy interventions in Switzerland and abroad.
Estill J, Ford N, Salazar-Vizcaya L, Haas AD, Blaser N, Habiyambere V, Keiser O (2016). The need for second-line antiretroviral therapy in adults in sub-Saharan Africa up to 2030: a mathematical modelling study. Lancet HIV 3(3):e132-9.
Tweya H, Keiser O, Haas AD, Tenthani L, Phiri S, Egger M, Estill J (2016). Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi. AIDS 30(6):953-62.
Estill J, Salazar-Vizcaya L, Blaser N, Egger M, Keiser O (2015). The Cost-Effectiveness of Monitoring Strategies for Antiretroviral Therapy of HIV Infected Patients in Resource-Limited Settings: Software Tool. PLoS One 10(3):e0119299.
Salazar Vizcaya L, Keiser O, Technau K, Davies MA, Haas AD, Blaser N, Cox V, Eley B, Rabie H, Moultrie H, Giddy J, Wood R, Egger M, Estill J (2014). Viral load versus CD4+ monitoring and 5-year outcomes of ART in HIV-positive children in Southern Africa: cohort based modelling study. AIDS 28(16):2451-60.
Estill J, Tweya H, Egger M, Wandeler G, Feldacker C, Johnson LF, Blaser N, Salazar Vizcaya L, Phiri S, Keiser O (2014). Tracing of patients lost to follow-up and HIV transmission: mathematical modeling study based on 2 large ART programs in Malawi. J Acquir Immune Defic Syndr 65(5):e179-86.
Estill J, Egger M, Johnson LF, Gsponer T, Wandeler G, Davies MA, Boulle A, Wood R, Garone D, Stringer JS, Hallett TB, Keiser O (2013). Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling study. PLoS One 8(2):e57611.
Estill J, Egger M, Blaser N, Salazar Vizcaya L, Garone D, Wood R, Campbell J, Hallett TB, Keiser O (2013). Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study. AIDS 27(9):1483-92.
Estill J, Aubrière C, Egger M, Johnson L, Wood R, Garone D, Gsponer T, Wandeler G, Boulle A, Davies MA, Hallett TB, Keiser O (2012). Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis. AIDS 26(11):1403-13.
Weigel R*, Estill J*, Egger M, Harries AD, Makombe S, Tweya H, Jahn A*, Keiser O* (2012). Mortality and loss to follow-up in the first year of ART: Malawi national ART programme. AIDS 26(3):365-73. (*Equal contribution)
The full publication list of publications can be found here: http://www.ncbi.nlm.nih.gov/pubmed/?term=estill+j%5Bauthor%5D+NOT+estill+jc%5Bauthor%5D+NOT+1990%5Bdp%5D+NOT+1991%5Bdp%5D+NOT+1996%5Bdp%5D+NOT+2005%5Bdp%5D+NOT+2008%5Bdp%5D